🔴 Abcellera Biologics is trading 5.6% down with broader market weakness a possible factor

Abcellera Biologics is trading at $11.55, down 5.64%; broader risk-off sentiment may be a factor, though its role is unconfirmed.

• No clear company-specific announcement on October 22 explains the decline; the announced ABCL635 poster presentation was scheduled for later that day.
• Supplied market context showed the Nasdaq down more than 0.5%, while Bloomberg reported biotechnology shares were pressured by rising Treasury yields; available evidence does not directly confirm either factor caused this move.